Anne Marinier

11PUBLICATIONS
104CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Biologically active moleculesHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 20, 2026
Targeting the H/KRAS α4-β6-α5 Allosteric Lobe with Macrocyclic Peptides.

|Feb 09, 2026
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.

Jasmin Coulombe-Huntington, Thierry Bertomeu, Caroline Huard

|May 29, 2025
BRAF oncogenic mutants evade autoinhibition through a common mechanism.

Hugo Lavoie, Ting Jin, Driss Lajoie

|Apr 28, 2025
DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition.

Céline Moison, Rodrigo Mendoza-Sanchez, Deanne Gracias

|Mar 22, 2024
SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.

Céline Moison, Deanne Gracias, Julie Schmitt

|Jul 07, 2022
HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.

Céline Moison, Jean-François Spinella, Jalila Chagraoui

Pageof 2

Frequent Collaborators

4 joint publications

Pierre Thibault

4 joint publications

Doris A Schuetz

3 joint publications

Hugo Lavoie

3 joint publications

Guy Sauvageau